Benzhydryl Compounds
Research News and Information

Sunday, November 22, 2009

The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men.

31 Aug 2009 Individual patterns of the electroencephalogram (EEG) in wakefulness and sleep are among the most heritable traits in humans, yet distinct genetic and neurochemical mechanisms underlying EEG phenotypes are largely unknown. A functional polymorphism ... Read more...

Armodafinil.

30 Aug 2009 Armodafinil is the R-enantiomer of modafinil, a wake-promoting agent, that primarily affects areas of the brain involved in controlling wakefulness. Once-daily armodafinil was effective in improving wakefulness in adult patients with excessive ... Read more...

Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine.

30 Aug 2009 OBJECTIVE: Fesoterodine, a new antimuscarinic agent for overactive bladder, undergoes immediate and extensive hydrolysis by nonspecific esterases to 5-hydroxymethyl tolterodine (5-HMT), the metabolite principally responsible for its antimuscarinic ... Read more...

Latest indexed articles for 'Benzhydryl Compounds'

These are the very latest articles for this heading:

• Disease mongering and excessive daytime sleepiness. 13 Oct 2009
• Turbocharging the brain. 29 Sep 2009
• The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. 31 Aug 2009
• Armodafinil. 30 Aug 2009
• Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine. 30 Aug 2009
• Tolterodine extended-release for overactive bladder. 30 Aug 2009
• A TRbeta-selective agonist confers resistance to diet-induced obesity. 25 Aug 2009
• Double anticholinergic therapy for refractory overactive bladder. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. 5 Aug 2009
• Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between mice. 30 Jul 2009
• Enantioselective separation and determination of adrafinil and modafinil on Chiralcel OJ-H column in rat serum and urine using solid-phase extraction followed by HPLC. 30 Jul 2009
• GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications. 30 Jul 2009
• Neuroimaging of narcolepsy. 30 Jul 2009
• Armodafinil for the treatment of excessive sleepiness. 30 Jul 2009
• Modafinil as a potential motion sickness countermeasure. 30 Jul 2009
• Hallucinations associated with modafinil treatment for narcolepsy. 30 Jul 2009
• Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Benzhydryl Compounds'

Definition: Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.

Registry Number: 0

Descriptor UI: D001559

Alternative terms: Benzhydryl Compounds; Compounds, Benzhydryl; Diphenylmethyl Compounds; Compounds, Diphenylmethyl;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.455.426.559.389.115;

History Note: 75

Technical Notes: DF: BENZHYDRYL CPDS